Non-Hodgkin's Lymphoma
Showing NaN - NaN of 33
Acute Myelogenous Leukemia, GVHD, Acute Lymphoblastic Leukemia Trial in Boston (sirolimus, tacrolimus)
Completed
- Acute Myelogenous Leukemia
- +6 more
-
Boston, MassachusettsDana-Farber Cancer Center
Jan 24, 2012
Non-Hodgkin's Lymphoma Trial in United States (autologous immunoglobulin idiotype-KLH conjugate vaccine)
Terminated
- Non-Hodgkin's Lymphoma
- autologous immunoglobulin idiotype-KLH conjugate vaccine
-
Los Angeles, California
- +8 more
Mar 14, 2008
Non-Hodgkin's Lymphoma Trial in United States (Zevalin (ibritumomab tiuxetan), Rituxan (rituximab))
Terminated
- Non-Hodgkin's Lymphoma
- Zevalin (ibritumomab tiuxetan)
- Rituxan (rituximab)
-
Huntsville, Alabama
- +66 more
Sep 8, 2006
Non-Hodgkin's Lymphoma Trial in United States (Xcellerated T Cells)
Unknown status
- Non-Hodgkin's Lymphoma
- Xcellerated T Cells
-
Greenbrae, California
- +17 more
Jun 23, 2005
Non-Hodgkin's Lymphoma Trial in Chicago, Boston, New York (Iodine-131 Anti-B1 Antibody)
Unknown status
- Non-Hodgkin's Lymphoma
- Iodine-131 Anti-B1 Antibody
-
Chicago, Illinois
- +2 more
Jun 23, 2005